文献速递甲状腺疾病

促甲状腺激素与甲状腺激素(三碘甲状腺原氨酸和甲状腺素):美国甲状腺协会委托的当前临床与实验室现状综述

Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status.
PubMed 文献 · Thyroid · 2023-09-01

美国甲状腺协会(ATA)委托国际跨学科工作组综述当前常规TSH和甲状腺激素检测的临床应用现状,指出生理、病理生理和药物因素可影响检测结果解读,方法学进步但分析干扰仍存,标准化需持续国际努力,质谱等新技术尚需更多证据方可常规使用,强调临床与实验室紧密协作。

要点

  • 甲状腺检测是常规内分泌检查,但结果解读可能 ambiguous,需结合临床背景。
  • 生理、病理生理和药物因素可影响甲状腺检测测量并混淆结果解读。
  • 常规甲状腺检测仍易受特异性分析干扰产生虚假结果,标准化需持续国际努力。

核心结论

  • 过去五十年TSH、T4和T3检测从手动放射性免疫分析发展为高度自动化非同位素多重免疫分析,但医生和检验人员必须理解方法局限性以正确开具检测和解读结果。

研究设计与样本

  • 美国甲状腺协会(ATA)委托国际跨学科工作组,通过回顾近期文献调查甲状腺检测现状,并在相互同意下修订或更新标准以指导临床 care。

主要发现

  • 甲状腺检测是执行最多的实验室内分泌检查,但其最佳使用和结果解读仍存疑问且可能 ambiguous。
  • 生理、病理生理和药物因素与甲状腺检测的相互作用可影响测量并混淆结果解读,需结合患者临床背景考虑。
  • 尽管过去50年实验室方法有显著进步,常规甲状腺检测仍易受特异性分析干扰而产生虚假结果。
  • 不同检测结果需通过持续国际努力证明改进的标准化后方可视为等效。
  • 新兴技术(如质谱法)在改进分析性能方面显示前景,但在可考虑常规使用前需更多临床效用和通量改善的证据。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Despite being the most performed laboratory endocrine investigation, the optimum use of thyroid tests (thyrotropin [TSH] and thyroid hormone [TH] measurement) is open to question and the interpretation of the results from these tests can be ambiguous. The American Thyroid Association (ATA) with its expertise support the endeavor of the U.S. Centers for Disease Control (CDC) and the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) to improve and maintain standardization and harmonization of thyroid testing. ATA mandated an international interdisciplinary working group panel to survey the status of thyroid testing by reviewing the recent literature to revise or update the criteria as needed in mutual agreement and to inform clinical care. Summary: This review represents the conclusions on the clinical use of current routine TSH and TH (thyroxine [T4] and triiodothyronine [T3]) assays, taking into account geographic differences in disease prevalence and clinical and laboratory practice among writing members. The interaction between physiological, pathophysiological, and pharmacological factors and thyroid assays can affect their measurements and confound result interpretation. These factors need to be considered in the clinical context of the patient for appropriate test ordering and result interpretation. Despite significant advances in laboratory methods over the past 50 years, routine thyroid assays remain susceptible to idiosyncratic analytical interference that may produce spurious results. Improved standardization needs to be demonstrated through ongoing international efforts before results from different assays can be considered equivalent. Emerging technology (e.g., mass spectrometry) shows promise for improved analytical performance, but more evidence of its clinical utility and improved throughput is required before it can be considered for routine use. Close clinical-laboratory collaboration is encouraged to overcome and avoid the pitfalls in thyroid testing as well as resolve clinically discrepant results. The evidence base supporting the conclusions of this review is summarized in four detailed online technical supplements. Conclusions: Over the past five decades, testing for TSH, T4, and T3 has evolved from manual radioisotopic immunoassays to nonisotopic multiplexed immunometric assays using highly automated equipment. Despite these technical advances, physicians and laboratorians performing these analyses must understand limitations of these methods to properly order tests and interpret results.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Van Uytfanghe K, Ehrenkranz J, Halsall D, et al. Thyroid Stimulating Hormone and Thyroid Hormones (Triiodothyronine and Thyroxine): An American Thyroid Association-Commissioned Review of Current Clinical and Laboratory Status. Thyroid. 2023. PMID: 37655789. doi:10.1089/thy.2023.0169

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。